These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 15878822)

  • 1. Rise in ciprofloxacin resistance in Escherichia coli from urinary tract infections from 1999-2004.
    Barisić Z; Borzić E; Kraljević KS; Carev M; Zoranić V; Kaliterna V
    Int J Antimicrob Agents; 2005 Jun; 25(6):550-1. PubMed ID: 15878822
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
    Arslan H; Azap OK; Ergönül O; Timurkaynak F;
    J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High percentage of resistance to ciprofloxacin and qnrB19 gene identified in urinary isolates of extended-spectrum beta-lactamase-producing Escherichia coli in Madrid, Spain.
    Ríos E; Rodríguez-Avial I; Rodríguez-Avial C; Hernandez E; Picazo JJ
    Diagn Microbiol Infect Dis; 2010 Aug; 67(4):380-3. PubMed ID: 20638608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Quinolone resistance of Escherichia coli strains isolated from urinary tract infections].
    Agulla A; Montes I
    Enferm Infecc Microbiol Clin; 1994; 12(6):322. PubMed ID: 8080877
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro activity of fosfomycin against ciprofloxacin-resistant or extended-spectrum beta-lactamase-producing Escherichia coli isolated from urine and blood.
    Ko KS; Suh JY; Peck KR; Lee MY; Oh WS; Kwon KT; Jung DS; Lee NY; Song JH
    Diagn Microbiol Infect Dis; 2007 May; 58(1):111-5. PubMed ID: 17300900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinolone resistance in female outpatient urinary tract isolates of Escherichia coli: age-related differences.
    Gobernado M; Valdés L; Alós JI; Garcia-Rey C; Dal-Ré R; García-de-Lomas J;
    Rev Esp Quimioter; 2007 Jun; 20(2):206-10. PubMed ID: 17893757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trimethoprim and ciprofloxacin resistance and prescribing in urinary tract infection associated with Escherichia coli: a multilevel model.
    Vellinga A; Tansey S; Hanahoe B; Bennett K; Murphy AW; Cormican M
    J Antimicrob Chemother; 2012 Oct; 67(10):2523-30. PubMed ID: 22729920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissemination of clonal groups of uropathogenic Escherichia coli is not a significant contributor to trimethoprim and sulfamethoxazole resistance in Galway, Ireland.
    Morris D; Ni Chulain M; Cormican M
    Int J Antimicrob Agents; 2007 Jul; 30(1):97-8. PubMed ID: 17459666
    [No Abstract]   [Full Text] [Related]  

  • 9. Evolution of fluoroquinolone resistance among Escherichia coli urinary tract isolates from a French university hospital: application of the dynamic regression model.
    Mahamat A; Lavigne JP; Fabbro-Peray P; Kinowski JM; Daurès JP; Sotto A
    Clin Microbiol Infect; 2005 Apr; 11(4):301-6. PubMed ID: 15760427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates.
    Caron F; Etienne M
    Am J Med; 2010 Mar; 123(3):e13. PubMed ID: 20193811
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro activity of prulifloxacin against Escherichia coli isolated from urinary tract infections and the biological cost of prulifloxacin resistance.
    Gualco L; Schito AM; Schito GC; Marchese A
    Int J Antimicrob Agents; 2007 Jun; 29(6):679-87. PubMed ID: 17363225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-microbial resistance stratified by risk factor among Escherichia coli strains isolated from the urinary tract at a rural clinic in Central India.
    Chatterjee B; Kulathinal S; Bhargava A; Jain Y; Kataria R
    Indian J Med Microbiol; 2009; 27(4):329-34. PubMed ID: 19736402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection of ciprofloxacin resistance in Escherichia coli in an in vitro kinetic model: relation between drug exposure and mutant prevention concentration.
    Olofsson SK; Marcusson LL; Komp Lindgren P; Hughes D; Cars O
    J Antimicrob Chemother; 2006 Jun; 57(6):1116-21. PubMed ID: 16624874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of sulphonamide resistance and class 1 integron genes in Escherichia coli isolates obtained from broilers, broiler meat, healthy humans and urinary infections in Denmark.
    Trobos M; Jakobsen L; Olsen KE; Frimodt-Møller N; Hammerum AM; Pedersen K; Agersø Y; Porsbo LJ; Olsen JE
    Int J Antimicrob Agents; 2008 Oct; 32(4):367-9. PubMed ID: 18583102
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of lactoferricin on fluoroquinolone susceptibility of uropathogenic Escherichia coli.
    Longhi C; Marazzato M; Conte MP; Iebba V; Schippa S; Seganti L; Comanducci A
    J Antibiot (Tokyo); 2009 Feb; 62(2):109-11. PubMed ID: 19198637
    [No Abstract]   [Full Text] [Related]  

  • 16. Resistance to fluoroquinolones and treatment failure/short-term relapse of community-acquired urinary tract infections caused by Escherichia coli.
    Gagliotti C; Buttazzi R; Sforza S; Moro ML;
    J Infect; 2008 Sep; 57(3):179-84. PubMed ID: 18707763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the mechanisms of fluoroquinolone resistance in urinary tract pathogens.
    Chenia HY; Pillay B; Pillay D
    J Antimicrob Chemother; 2006 Dec; 58(6):1274-8. PubMed ID: 17040923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary tract infections and a multidrug-resistant Escherichia coli clonal group.
    Sandel DC; Wang CT; Kessler S
    N Engl J Med; 2002 Feb; 346(7):535-6. PubMed ID: 11844861
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of low-level fluoroquinolone resistance genes qnrA1, qnrB19 and qnrS1 on ciprofloxacin treatment of isogenic Escherichia coli strains in a murine urinary tract infection model.
    Jakobsen L; Cattoir V; Jensen KS; Hammerum AM; Nordmann P; Frimodt-Møller N
    J Antimicrob Chemother; 2012 Oct; 67(10):2438-44. PubMed ID: 22685162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endemic occurrence of infections by multidrug-resistant Escherichia coli of four unique serotypes in the elderly population of Israel.
    Wolk M; Valinsky L; Sompolinsky D; Sechter I; Schmidt H; Tetry S; Agmon V
    FEMS Microbiol Lett; 2004 Oct; 239(2):249-54. PubMed ID: 15476973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.